Professional Documents
Culture Documents
▪ for the first time after mid-pregnancy → Blood pressure reaches 140/90 mm Hg or greater + proteinuria is not identified.
▪ by 12 weeks postpartum → Transient hypertension and blood pressure returns to normal
Women with gestational hypertension are at risk for progression to either severe hypertension, pre-eclampsia, or eclampsia
Close fetal monitoring is necessary.
In absence of progression to severe hypertension or pre-eclampsia
women with gestational hypertension can continue pregnancy until term.
During labor and immediately postpartum, they do not require seizure prophylaxis because rate of eclampsia < 1 in 500.
Preeclampsia
Definition:
Risk Factors:
Pathology:
Diagnosis:
Fetal Maternal:
▪ Iatrogenic prematurity and its complications. ▪ Central nervous system
▪ IUGR Cerebral hemorrhage(commonest cause of death)& edema,
▪ IUFD Cortical blindness
▪ Respiratory system: Laryngeal edema, Pulmonary edema
▪ Renal system: renal failure
▪ Liver: Jaundice, Hepatic infarction, Hepatic rupture
▪ Coagulation system: DIC, Micro-angiopathic hemolysis.
▪ Eclampsia .
▪ Placenta: Red infarction, Retroplacental bleeding + abruptio placentae
▪ Remote : residual HPN, residual proteinuria& recurrence.
Investigations
Labouratory findings:
▪ Renal function (deteriorated only in severe cases):
▪ CBC:
↑Serum uric acid + ↑Creatinine + ↑BUN.
hematocrit value
↓Creatinine clearance
Microcytic hemolytic anemia
▪ Liver functions
Thrombocytopenia.
↑liver enzymes (ALT&AST) + ↑ LDH.
▪ Urine analysis: Oliguria, proteinuria, hypocalciuria.
▪ Coagulation profile is disturbed in DIC
Other investigation:
Differential diagnosis:
4. D.D of HELLP syndrome
1. D.D of hypertension with pregnancy: ▪ Acute fatty liver in pregnancy
▪ PIH, preeclampsia and superimposed preeclampsia. rare disease with unclear etiology + poor prognosis
▪ Essential hypertension & 2ry hypertension: Acute, rapidly progressing liver failure
▪ Chronic nephritis. with heavy hepatic infiltration with fat.
▪ Thyrotoxicosis(systolic HPN). ▪ Viral or drug induced hepatitis.
▪ Coarctation of aorta (differential HPN ). ▪ Thrombocytopenic purpura.
▪ Pheochromocytoma ▪ Hemolytic-uremic syndrome
(medulla of suprarenal gland, diagnosed by ↑VMA) Very rare & poor prognosis→ severe acute renal failure,
2. D.D of edema with pregnancy microangiopathic hemolytic anemia, thrombocytopenic purpura.
Unilateral bilateral
DVT Physiological Pathological
Cellulitis "pregnancy" ▪ Preeclampsia
▪ Renal,hepatic,cardiac,nutritional + angioneurotic
3. D.D of proteinuria with pregnancy:
▪ Contamination of the specimen with vaginal discharge( commonest cause).
▪ Urinary tract infection. ▪ Orthostatic proteinuria (rare and insignificant)
▪ Preeclampsia. present at the end of day and
▪ Renal hypoxia as in cases of CHF and severe anemia. disappears at morning dt stretch of left renal vein
▪ Anaemia. over 5th lumbar vertebrae in standing position
▪ Congestive heart failure. dt lumbar lordosis.
▪ Rarely in severe cases with hyperemesis gravidarum.
Prevention of pre-eclampsia:
▪ A variety of strategies used to prevent or modify the severity of preeclampsia have been evaluated.
▪ In general, none of these has been found to be clinically efficacious.
Examples → Dietary calcium , vit D + low-dose aspirin,
Pathology:
▪ As pre-eclampsia and Cerebral Pathology which may be cerebral edema, ischemia or infarction
leading to hypertensive encephalopathy manifested by convulsions
1. CT Scanning:
Cerebral edema,hemorrhage(Cerebral ,intraventricular hemorrhage, parenchymal hemorrhage)& Cerebral infarction
2. Magnetic Resonance Imaging of brain
3. Electroencephalography and CSF Studies
Differential diagnosis:
▪ Women with a history of eclampsia are at increased risk for all forms of pre-eclampsia in subsequent pregnancies.
Preeclampsia eclampsia
Expectant treatment (medical ) Medical
General General
1. Rest 1. Rest : single , quiet semidark room equipped + suction apparatus , mouth gag.
2. Diet : NPO.
2. Observations: 3. Observation :
• Frequently → vital signs , symptoms , urine output • Maternal coma duration , convulsion number & vital signs.
• Lab. Investigation (KFT , LFT , CBC, …etc). • fetal U/S. to document fetal viability.
• U/S & assessment of fetal wellbeing 4. Drugs →
3. Specific: Control of hypertension: Antihypertensive
Parenteral drugs (in severe cases) parentral (Hydralazine or labetalol)
• Hydralazine → peripheral vasodilator → palpitation. to maintain systolic BP between 140 - 160 mm Hg
• Labetalol → alpha1 and none selective beta adrenergic blocker. diastolic BP between 90 - 110 mm Hg
Oral anti-hypertensive: Anticonvulsants → Magnesium Sulfate, valium , Na thiopental &epanutin
• Alpha methyl DOPA (aldomet) Second-Line Medications:
acts centrally Max. • Diazepam + Clonazepam .
dose is 2 g/day • Phenytoin (epanutin) to prevent and treat convulsions.
SE→ postural hypotension, depression, night mares Although it widely used anticonvulsant drug, its use in eclampsia is limited
less commonly cholestatic jaundice + hemolytic anemia (+ve coombs test). Care must be taken not to the BP too drastically;
• Beta blockers → labetalol . + CCB → nifedipine an excessive → inadequate uteroplacental perfusion and fetal distress
Obstetric 5. Complications:
Timing • Glucose → nutrition , supports liver.
Mild cases: Severe cases: • Atropine→↓ bronchial secretion.
▪ GA ≥ 37 wks: ▪ Gestational age ≥ 34 weeks • Digitalis→ in H.F. *Diuretics only in the setting of pulmonary edema.
termination of pregnancy T.O.P. • Oxygen
▪ Gestational age < 37 wks: ▪ Gestational age < 34 weeks: Obstetric
expectant till maturity then management is controversial Timing
termination TOP or conservative till 34 wk. 3 – 6 hours to stabilize general condition then termination.
Method (VD Vs CS.) Method
• vaginal delivery should be attempted if no indications for cesarean delivery. ▪ based on obstetric indications however vaginal delivery is preferable .
Postnatal care ▪ Cesarean delivery may be considered in patients with
▪ Continue antenatal antiHTN ttt (If methyldopa used, stop within 2 days of birth) unfavorable cervix // gestational age of 30 weeks or less.
▪ Stop antihypertensive treatment if BP falls to < 130/80 mmHg. ▪ vaginal delivery → same precautions as PE
▪ Measure BP at least 4 times a day while inpatient. Postpartum
▪ Measure platelet count, transaminases and creatinine 48-72 hours after birth. Parenteral magnesium sulfate
▪ Postnatal review (6-8 weeks after birth) continued for at least 24 hours after delivery or
✓ Offer medical review for at least 24 hours after last convulsion.
✓ Offer referral for specialist assessment if antihypertensive ttt still needed. oral antihypertensive as labetalol or nifedipine
✓ Repeat platelet count, transaminases and serum creatinine measurements to keep systolic BP < 155 mm Hg and
if indicated. diastolic BP < 105 mm Hg.
✓ Referral for specialist kidney assessment, if proteinuria ≥ 1+ (Nifedipine offers benefit of improved diuresis in the postpartum period).
Rest of Ttt of PE
Fetal Maternal
▪ Severe growth restriction ▪ Persistent severe headache or visual changes; eclampsia
▪ Persistent severe oligohydramnios (AFI < 5 cm) ▪ Shortness of breath; chest tightness , pulmonary edema
▪ Biophysical profile ≤4 done 6 hr apart ▪ Uncontrolled severe hypertension despite treatment
▪ Reversed end-diastolic umbilical artery flow ▪ Oliguria < 500 mL/24 hr or serum creatinine ≥1.5 mg/dl
▪ Fetal death ▪ Persistent platelet counts < 100,000/mm3
▪ Suspected abruption, progressive labour, and/or ruptured membranes
Magnesium Sulfate
is the drug of choice to treat and prevent subsequent convulsion
Dose: Loading dose Maintenance dose
4-6 gm in 100ml fluid IV initially over 15-20 min. 1-2g/hr to maintain effect with close monitoring of mg level in serum every 4 6hrs.
(Therapy is stopped 24hrs after delivery).
Mechanism: • Anticonvulsant
CNS depression . • Vasodilator
inhibits release of Acetyl choline at motor end plate. • diuretic
inhibits intracellular ca influx .
Toxicity 8mEq/L 12mEq/L > 15 mEq/L
• patellar reflex is lost. respiratory depression. • cardiac conduction is disturbed
• myometrial inhibition starts • death may occur
Treatment →calcium gluconate or calcium chloride (antidote),
1 gm intravenously, along with withholding further magnesium sulfate Maintain levels between 4 and 7 mEq/L (4.8 to 8.4 mg/dL).
Before giving dose, the following should be confirmed:
o Present patellar reflex + Respiratory rate> 16/min . + Urine output >100 ml/4hrs.
Superimposed pre-eclampsia on chronic hypertension
▪ New onset proteinuria in hypertensive women after 20 weeks' gestation, or
▪ sudden increase in proteinuria or blood pressure
Chronic Hypertension
Def
Etiology
Classification:
• Mild.
• Severe
Systolic and diastolic BP of at least 180 mm Hg or 110 mm Hg, respectively
▪ In most women with chronic hypertension, blood pressure in early pregnancy and then during 3rd trimester
to levels somewhat above those in early pregnancy.
Fetal Maternal
• IUGR • Superimposed Pre-eclampsia
• Preterm Delivery • Placental Abruption
• Life-threatening complications such as
hypertensive encephalopathy, cerebral hemorrhage- retinopathy
acute renal failure - Pulmonary edema,
Management
Pre-conceptional Evaluation